• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q/A filed by Omega Alpha SPAC (Amendment)

    9/16/22 4:00:26 PM ET
    $OMEG
    Business Services
    Finance
    Get the next $OMEG alert in real time by email
    0001832010 false --12-31 2022 Q1 0001832010 2022-01-01 2022-03-31 0001832010 omeg:ClassAOrdinarySharesMember 2022-09-16 0001832010 omeg:ClassBOrdinarySharesMember 2022-09-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 10-Q/A

    (Amendment No. 1)

     

     

    (Mark One)

    x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the quarterly period ended March 31, 2022

     

    ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the transition period from             to          

     
     
    OMEGA ALPHA SPAC

    (Exact name of registrant as specified in its charter) 

     

     

    Cayman Islands 001-039840 98-1566615
    (State or other jurisdiction of
    incorporation or organization)
    (Commission
    File Number)
    (I.R.S. Employer
    Identification Number) 

     

    888 Boylston Street, Suite 1111 
    Boston, MA
    02199
    (Address of principal executive offices) (Zip Code)

     

    (857) 268-4429

    Registrant’s telephone number, including area code

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of Each Class:   Trading
    Symbol:
      Name of Each Exchange
    on Which Registered:
    Class A ordinary shares, $0.0001 par value per share   OMEG   The NASDAQ Capital Market LLC

     

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

     

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ¨ Accelerated filer ¨
    Non-accelerated filer x Smaller reporting company x
    Emerging growth company x    

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ 

     

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes x No ¨

     

    As of September 16, 2022, 14,301,000 Class A ordinary shares, par value $0.0001 per share, and 3,450,000 Class B ordinary shares, par value $0.0001 per share, were issued and outstanding.

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    References throughout this Amendment No. 1 to the Quarterly Report on Form 10-Q/A to “we,” “us,” the “Company” or “our company” are to Omega Alpha SPAC unless the context otherwise indicates.

     

    This Amendment No. 1 to the Quarterly Report on Form  10-Q/A (this “Amendment No. 1”) amends the Quarterly Report on Form  10-Q of Omega Alpha SPAC (the “Company”) as of and for the quarterly period ended March 31, 2022, as filed with the Securities and Exchange Commission (“SEC”) on May 13, 2022 (the “Original 10-Q Filing”).

     

    The Company has been informed by the SEC on September 9, 2022 of an error resulting from the omission of the introductory language in the Certifications 31.1 and 31.2 referring to internal control over financial reporting in paragraph 4 and paragraph 4(b) language referring to internal control over financial reporting included in the Original 10-Q Filing.

     

    We are filing this Amendment No. 1 to amend and restate the Original 10-Q Filing with modification as necessary to reflect the changes in the Certifications. The following items have been amended:

     

    Exhibit 31.1. Certification of Chief Executive Officer Pursuant to Rule 13a-14 and 15d-14 under the Securities Exchange Act of 1934, as amended.

     

    Exhibit 31.2. Certification of Chief Financial Officer Pursuant to Rule 13a-14 and 15d-14 under the Securities Exchange Act of 1934, as amended.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 16th day of September, 2022.

     

      OMEGA ALPHA SPAC 
       
      By: /s/ Otello Stampacchia
        Name: Otello Stampacchia
        Title: Chief Executive Officer 
         
      By: /s/ Francesco Draetta
        Name: Francesco Draetta
        Title: Chief Financial Officer

     

     

     

    Get the next $OMEG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OMEG

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $OMEG
    SEC Filings

    View All

    SEC Form 15-12G filed by Omega Alpha SPAC

    15-12G - Omega Alpha SPAC (0001832010) (Filer)

    1/6/23 6:11:33 AM ET
    $OMEG
    Business Services
    Finance

    SEC Form 25-NSE filed by Omega Alpha SPAC

    25-NSE - Omega Alpha SPAC (0001832010) (Subject)

    12/27/22 4:15:27 PM ET
    $OMEG
    Business Services
    Finance

    Omega Alpha SPAC filed SEC Form 8-K: Other Events

    8-K - Omega Alpha SPAC (0001832010) (Filer)

    12/23/22 4:05:26 PM ET
    $OMEG
    Business Services
    Finance

    $OMEG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Omega Funds Closes Oversubscribed $650 Million Fund VII to Invest in Transformative Life Science Companies

    BOSTON, Dec. 17, 2021 /PRNewswire/ -- Omega Funds, a leading international healthcare venture capital firm focused on delivering impactful medicines to patients, today announced it has closed its seventh and largest fund with $650 million in limited partner capital commitments. The new fund, Omega Fund VII, L.P. ("Fund VII"), was oversubscribed, exceeding the firm's targeted raise of $500 million, and included strong support from both new and existing limited partners. With Fund VII, the firm will continue to execute on its strategy of creating and investing in life sciences companies in the US and Europe that target severe, unmet medical needs. Since its inception in 2004, Omega Funds has r

    12/17/21 8:00:00 AM ET
    $ADGI
    $ICVX
    $IKNA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Business Services

    $OMEG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Omega Alpha SPAC (Amendment)

    SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)

    2/14/23 2:16:43 PM ET
    $OMEG
    Business Services
    Finance

    SEC Form SC 13G/A filed by Omega Alpha SPAC (Amendment)

    SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)

    2/14/23 7:41:31 AM ET
    $OMEG
    Business Services
    Finance

    SEC Form SC 13G/A filed by Omega Alpha SPAC (Amendment)

    SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)

    2/9/23 11:07:54 AM ET
    $OMEG
    Business Services
    Finance